USD 13.92 billion
Retinal Vein Occlusion Treatment Market Size, Share, Growth Analysis, By Disease Type(Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)), By Treatment(Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, and Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2215 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
62
|Figures:
70
Retinal Vein Occlusion Treatment Market Insights
Global Retinal Vein Occlusion Treatment Market size was valued at USD 13.92 billion in 2022 and is poised to grow from USD 15.41 billion in 2023 to USD 34.75 billion by 2031, growing at a CAGR of 10.70% during the forecast period (2024-2031).
The retinal vein occlusion treatment market is witnessing notable growth due to the increasing incidence of retinal vein occlusion (RVO) and the growing aging population prone to this condition. RVO is a common retinal vascular disorder leading to vision impairment and blindness if not promptly treated. This market encompasses various treatment options, including medications, laser therapy, and surgical interventions, aimed at improving blood circulation, reducing macular edema, and preventing vision loss.
The market is segmented based on treatment type, end-user, and region. Anti-VEGF medications are a prominent treatment option, helping to control abnormal blood vessel growth and macular edema. The growing acceptance of advanced therapies and the rise in RVO cases are driving the market's expansion. North America and Europe are leading regions due to well-established healthcare infrastructure, increased healthcare expenditure, and early adoption of novel treatment techniques. The Asia-Pacific region is also growing, driven by rising healthcare awareness and improving medical facilities.
Factors such as increasing investment in research and development, advancements in diagnostic techniques, and collaboration among pharmaceutical companies and research institutions are boosting the development of innovative treatment methods. Additionally, the rising focus on personalized medicine and patient-centric approaches is expected to drive the market forward. As the demand for effective RVO treatments continues to surge, manufacturers and healthcare providers are working together to provide more accessible and efficient solutions to improve the quality of life for individuals affected by this condition.
US Retinal Vein Occlusion Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Central Retinal Vein Occlusion (CRVO)
Fastest Growth
Central Retinal Vein Occlusion (CRVO)
Growth Rate
10.70% CAGR
Global Retinal Vein Occlusion Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Retinal Vein Occlusion Treatment Market Segmental Analysis
The retinal vein occlusion treatment market is segmented on the basis of disease type, treatment, end-user, and regional. Based on Disease Type the market is segmented as, Central Retinal Vein Occlusion (CRVO),, Branch Retinal Vein Occlusion (BRVO). Based on Treatment the market is segmented as, Anti-vascular Endothelial Growth Factor (Anti-VEGF),, Corticosteroid Drugs, And Others. Based on End-user the market is segmented as, Hospital & Clinics,, Research and Academics, Others. Based on Regional the market is segmented as, North America, Asia Pacific, Latin America
Retinal Vein Occlusion Treatment Market Analysis By Treatment
The retinal vein occlusion treatment market analysis by treatment encompasses a comprehensive evaluation of therapeutic approaches used to manage this vision-threatening condition. The market is segmented based on various treatment options, including anti-VEGF therapies, corticosteroids, laser therapy, and surgical interventions. Anti-VEGF therapies have gained prominence, offering targeted inhibition of vascular endothelial growth factor to reduce macular edema and improve visual outcomes. Corticosteroids provide anti-inflammatory effects and are used for cases resistant to or unsuitable for anti-VEGF treatment. Laser therapy aims to reduce macular edema through photocoagulation, while surgical interventions are reserved for severe cases with complications.
The market analysis also considers regional variations, with North America and Europe holding substantial market shares due to advanced healthcare infrastructure and higher prevalence of retinal vein occlusion cases. The Asia-Pacific region is witnessing growth due to increasing awareness, improving healthcare facilities, and rising cases of retinal vein occlusion. The market is influenced by factors such as technological advancements in treatment methods, greater emphasis on early diagnosis, and collaborative efforts between pharmaceutical companies, research institutions, and healthcare providers. The increasing aging population and the associated higher risk of retinal vein occlusion contribute to market expansion as well.
Retinal Vein Occlusion Treatment Market Analysis By Disease Type
The retinal vein occlusion (RVO) treatment market analysis is categorized based on the type of disease, offering insights into the management of retinal vein occlusion and its various manifestations. RVO refers to the blockage of veins that carry blood away from the retina, causing vision impairment. The market analysis focuses on two main types of RVO: central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
Central retinal vein occlusion (CRVO) occurs when the main vein carrying blood out of the retina is blocked, leading to decreased blood flow and potential macular edema. This type of RVO is further classified into non-ischemic and ischemic CRVO, depending on the severity of blood flow disruption and associated complications.
Branch retinal vein occlusion (BRVO) involves the blockage of smaller veins that drain a particular section of the retina. It can lead to macular edema, vision loss, and complications like retinal neovascularization. The analysis of this segment encompasses the evaluation of treatments targeting the specific area affected by the blocked vein.
The analysis of the RVO treatment market by disease type provides valuable insights into the prevalence, diagnostic techniques, and treatment options available for each category. It aids in understanding the therapeutic landscape and advancements in the medical field aimed at managing retinal vein occlusion and improving visual outcomes for patients. The market analysis also takes into account the evolving research and development efforts to introduce innovative therapies that address the distinct challenges posed by central and branch retinal vein occlusion, ultimately contributing to better patient care and outcomes.
Global Retinal vein occlusion treatment market By Disease Type
To get detailed analysis on other segments, Request For Free Sample Report
Retinal Vein Occlusion Treatment Market Regional Insights
Regional insights in the retinal vein occlusion treatment market reveal variations in prevalence, healthcare infrastructure, and treatment approaches across different regions. North America holds a prominent position due to its advanced medical facilities, high healthcare expenditure, and increasing elderly population. Europe follows suit with its well-established healthcare systems and access to innovative treatments. Asia-Pacific exhibits promising growth potential due to a rising geriatric population, changing lifestyle factors, and improving healthcare infrastructure. Developing economies in this region, such as China and India, are witnessing increased prevalence of retinal vein occlusion, driving the demand for effective treatments. Latin America and the Middle East also contribute to the market growth, driven by improved healthcare awareness and growing investments in medical technologies. Overall, the regional landscape underscores the need for accessible and effective treatments to address retinal vein occlusion across diverse healthcare settings.
Global Retinal vein occlusion treatment market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Retinal Vein Occlusion Treatment Market Dynamics
Retinal Vein Occlusion Treatment Market Drivers
Growing Prevalence of Eye Diseases to Fuel Market Growth
- The retinal vein occlusion market is driven by several key factors, including the escalating global incidence of eye diseases, a growing geriatric population, improved understanding of eye disorders, bolstered healthcare facilities, technological advancements, and the emergence of novel therapies. The presence of a robust pipeline and recent approvals of new drugs further contribute to the momentum of the retinal vein occlusion market's growth. As the number of retinal vein occlusion cases rises, and more molecules are being researched for treatment, the efficacy of retinal vein occlusion therapy is also on the rise, supported by a strong pipeline and recent drug clearances. This trend holds the potential to greatly propel the market's expansion, presenting opportunities for embracing innovative retinal vein occlusion therapeutics.
Retinal Vein Occlusion Treatment Market Restraints
High Treatment-Related Costs Impedes Market Growth
- The bioresorbable scaffolds market faces a challenge in terms of limited long-term clinical evidence. The outcomes of bioresorbable scaffold implants compared to traditional stents need further evaluation to establish their efficacy and safety conclusively.
Request Free Customization of this report to help us to meet your business objectives.
Retinal Vein Occlusion Treatment Market Competitive Landscape
The competitive landscape of the retinal vein occlusion market offers comprehensive insights into each competitor's profile. These details encompass company overview, financial performance, revenue generation, market potential, investments in research and development, initiatives in new markets, global reach, production facilities, strengths and weaknesses, product launches, ongoing clinical trial pipelines, product approvals, patents, product diversity, application dominance, and the trajectory of technology adoption. The aforementioned data points pertain exclusively to the companies' endeavors pertaining to research in the global retinal vein occlusion market.
Retinal Vein Occlusion Treatment Market Top Player’s Company Profile
- Alcon
- Pfizer Inc.
- Genentech
- Regeneron Pharmaceuticals Inc.
- Allergan plc
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- Sanofi
- Thrombogenics Inc.
- Acucela Inc.
- Clearside Biomedical Inc
- EyePoint Pharmaceuticals Inc.
- Sirnaomics Inc.
- Astellas Pharma Inc.
- Bellus Health Inc.
Retinal Vein Occlusion Treatment Market Recent Developments
- In December 2020, Arctic Vision, a clinical-stage company specializing in ophthalmology and headquartered in China, achieved a significant milestone. They received approval for the Phase III Investigational New Drug (IND) for treating Uveitic Macular Edema (UME). This marked a notable accomplishment as it was the first clinical trial in China for UME therapy involving suprachoroidal space (SCS) injection. This novel approach aimed to introduce an alternative treatment option for UME patients in China.
- In December 2020, Novartis released positive outcomes from the initial interpretable results of a Phase III clinical trial evaluating the effectiveness and safety of their product Beovu. The findings showcased Beovu's potential, putting it in close competition with Eylea, a leading therapy developed by Regeneron for enhancing diabetic macular edema treatment.
Retinal Vein Occlusion Treatment Key Market Trends
Rising Prevalence and Aging Population:
- The increasing prevalence of retinal vein occlusion, particularly among the aging population, is driving the demand for effective treatment options. As the global population ages, the incidence of this condition is expected to rise, contributing to market growth.
Advancements in Therapeutic Approaches:
- The market is witnessing a shift towards innovative therapeutic approaches, including the development of targeted therapies, combination treatments, and gene therapies. These advancements aim to provide more effective and personalized solutions for retinal vein occlusion patients.
Retinal Vein Occlusion Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our Global Retinal Vein Occlusion Treatment Market analysis, the increasing prevalence of retinal vein occlusion disorders, the aging population, and advancements in medical technologies are the key drivers. This condition can lead to vision impairment and even blindness, thus necessitating effective treatment options. The market is segmented into treatment types, including anti-VEGF therapy, corticosteroid therapy, and laser therapy. Geographically, North America and Europe hold significant market shares due to well-established healthcare infrastructure and high adoption rates of advanced treatments. Asia-Pacific, with countries like China and India, presents growth opportunities owing to a rising geriatric population and improving healthcare facilities. Overall, the retinal vein occlusion treatment market is driven by the need for efficient therapies to address vision-threatening conditions and is expected to continue expanding globally.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 13.92 billion |
| Market size value in 2031 | USD 34.75 billion |
| Growth Rate | 10.70% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Retinal Vein Occlusion Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Retinal Vein Occlusion Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Retinal Vein Occlusion Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Retinal Vein Occlusion Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Retinal Vein Occlusion Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Retinal Vein Occlusion Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
